24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Short Wave Pharma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
15:46
Israel’s weapons remain in demand, but politics may decide who buys them
15:21
Israeli firm accused of using online ads to track Starlink users worldwide
13:04
“Intel will be among the first names people think of in quantum computing,” says Classiq CEO
10:59
Ofer Polivoda appointed Global Vice President of Client Success at Papaya Global
More stories
Buzz
Most popular
Daily
Weekly
1
Microsoft offers buyouts to 60,000 workers but says layoffs remain an option
2
Intel to acquire Israeli quantum startup Classiq for $2.3 billion
3
Palantir CEO says Israel is the "minor exception" in AI race dominated by U.S. and China
4
One-year-old AI unicorn Unconventional acquires Israeli chipmaker NeuReality
5
Classiq founders set to pocket up to $100 million each in Intel’s $2.3 billion deal
More news
Short Wave Pharma
1 stories about Short Wave Pharma
Biopharma company Short Wave partnering in clinical trial for eating disorders with Sheba Fund
16.08.22
|
CTech
The trial will study the safety and feasibility of psilocybin-assisted psychotherapy for the treatment of anorexia nervosa